Effects of Tazarotene 0.045% Lotion on Quality of Life in Patients With Moderate-to-Severe Acne

November 2020 | Volume 19 | Issue 11 | Original Article | 1086 | Copyright © November 2020


Published online October 30, 2020

Leon H. Kircik MD,a-c Edward Lain MD MBA,d Michael Gold MD,e,f Bruce Katz MD,a,g Hilary Baldwin MD,h Eric Guenin PharmD PhD MPH,i Anya Loncaric MS,j Radhakrishnan Pillai PhDj

aIcahn School of Medicine at Mount Sinai, New York, NY
bIndiana University School of Medicine, Indianapolis, IN
cPhysicians Skin Care, PLLC, Louisville, KY
dAustin Institute for Clinical Research, Austin, TX
eGold Skin Care Center, Nashville, TN
fTennessee Clinical Research Center, Nashville, TN
gJUVA Skin & Laser Center, New York, NY
hThe Acne Treatment and Research Center, Brooklyn, NY
iOrtho Dermatologics, Bridgewater, NJ*
jBausch Health US, LLC, Petaluma, CA*
*Ortho Dermatologics is a division of Bausch Health, US, LLC. Bausch Health US, LLC is an affiliate of Bausch Health Companies, Inc.